Evidence map›Paper›PMID 39174716›Full record

ReviewZeitschrift fur Rheumatologie2024

Castleman's disease in the rheumatological practice.

M Schmalzing, O Sander, M Seidl, R Marks, N Blank, I Kötter, M Tiemann, M Backhaus, B Manger, K Hübel and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M SchmalzingDepartment of Medicine and Polyclinic II, University Hospital Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Germany. Schmalzing_M@ukw.de.
O SanderDepartment of Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany.
M SeidlInstitute of Pathology, University Hospital Düsseldorf, Düsseldorf, Germany.
R MarksDepartment of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany.
N BlankUniversity Hospital Heidelberg, Heidelberg, Germany.
I KötterDepartment of Rheumatology and Immunology, Hospital Bad Bramstedt, Bad Bramstedt, Germany.
M TiemannInstitute of HematoPathology Hamburg, Hamburg, Germany.
M BackhausDept. of Internal Medicine-Rheumatology and Clinical Immunology, Park-Klinik Weissensee (Berlin), Berlin, Germany.
B MangerDepartment of Medicine 3-Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany.
K HübelDepartment of Internal Medicine, University Hospital Cologne, Cologne, Germany.
U Müller-LadnerDepartment of Rheumatology and Clinical Immunology, Kerckhoff Klinik Bad Nauheim, Bad Nauheim, Germany.
J HenesDepartment of Medicine II, University Hospital Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39174716
PMCPMC11655606

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.